Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Harbor MedTech
About
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.It offers NeuvoCell, a wound therapy for chronic wounds, such as diabetic, venous, and pressure ulcers; products for hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological repair; and Architect, a collagen matrix for treatment of partial and full-thickness skin wounds. Harbor MedTech, Inc. has a strategic partnership with Edwards Lifesciences.The company was founded in 2010 by Jim Jungwirth and Keith Myers and is based in Irvine, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 5, 2017 | Series C | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
